SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
2023 · Nature Medicine · 124 citations
https://doi.org/10.1038/s41591-023-02414-4
C
Charlotte Gaskell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
474
Citations
7
h-index
7
i10-index
Charlotte Gaskell is an academic researcher from Queen Elizabeth Hospital Birmingham. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Acute Myeloid Leukemia Research. The author has an h-index of 7, co-authored 21 publications.
ORCID: 0000-0002-6382-2277Papers by this author
worksAxitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
2023 · British Journal of Cancer · 10 citations
https://doi.org/10.1038/s41416-023-02416-6
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial
2025 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-024-13383-3
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)
2025 · BMJ Open · 1 citations
https://doi.org/10.1136/bmjopen-2024-086223
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-13890-x
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial
2025 · BMC Medical Research Methodology · 0 citations
https://doi.org/10.1186/s12874-025-02575-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat